Used in pharmaceutical research as a potent and selective inhibitor of protein kinases, particularly targeting pathways involved in cancer cell proliferation and survival. Shows promise in the development of targeted therapies for solid tumors and hematological malignancies. Its structure enables high binding affinity to specific kinase domains, improving selectivity and reducing off-target effects. Also employed in studies exploring signal transduction mechanisms and as a lead compound for optimizing drug candidates in oncology.